EGR1 and colorectal cancer: Since EGR1 is an essential regulator of cell survival, we tested the effect of TOLE, a nonsteroidal anti-inflammatory drug (NSAID) that induced cell death in an EGR1-dependent manner in colorectal cancer cells [24].